New Mexico
The Medical Assistance Division (MAD) of the New Mexico Human Services Department (HSD) is requiring all prescribers including pharmacists with prescriptive authority for Centennial Care members to enroll as a Medicaid Provider by November 12, 2022, to continue to receive payment for prescriptions. Failure to enroll as a Medicaid Provider will result in denial, rejection, or recoupment of payment for prescriptions when written for Centennial Care members.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
New York
As a result of PBM legislation enacted in 2021, the NYS Department of Financial Services is developing regulations, and the Department is seeking public comment on a series of issues.
Below are the three upcoming Public Notices with links for more details related to:
PBM Services to Medicare Part D Plans, Comments due August 1, 2022
View the Request for Public Comments (PDF) Responses should be emailed to PBM@dfs.ny.gov, with "PBM2022-02" included in the subject line. Failure to include "PBM2022-02" in the subject line may result in your comment not being considered. The deadline for responses is August 1, 2022.
Reporting Requirements for PBMs (Pharmacy Benefits Managers), Comments due August 5, 2022
View the Request for Public Comments (PDF) Responses should be emailed to PBM@dfs.ny.gov, with "PBM2022-03" included in the subject line. Failure to include "PBM2022-03" in the subject line may result in your comment(s) not being considered. The deadline for responses is August 5, 2022.
Practice of Patient Steering by PBMs due August 19, 2022
View the Request for Public Comments (PDF) Responses should be emailed to PBM@dfs.ny.gov, with "PBM2022-04" included in the subject line. Failure to include "PBM2022-04" in the subject line may result in your comment not being considered. The deadline for responses is August 19, 2022.
For more information about these Public Notices and DFS (Department of Financial Services) efforts to implement the law, please click here.
Also in New York, the Office of the Medicaid Inspector General (OMIG) published a Proposed Rule Making in the State Register related to Medicaid Program Fraud, Waste and Abuse Prevention with the stated purpose to establish requirements for providers to detect and prevent fraud, waste, and abuse in the Medicaid Program.
The full text of the proposed rule can be found here. Public comments are due within 60 days from when published on July 13, 2022. To read the new sections added to OMIG regulation through this rulemaking in their entirety, please click here.
In particular, the proposed rulemaking would repeal and add a new 18 NYCRR Part 521 to implement statutory changes resulting from the recommendations of the Medicaid Redesign Team II as adopted in the State Fiscal Year 2020-2021 Enacted Budget (Chapter 56 of the Laws of 2020, Part QQ) and to make other conforming changes related to:
(1) Provider Compliance Programs,
(2) Medicaid Managed Care Plan fraud, waste, and abuse prevention programs under the Medical Assistance (Medicaid) program, and
(3) The Obligation to report, return and explain Medicaid overpayments through OMIG's Self-Disclosure Program.
For more information, please contact NACDS’ Mike Sargent at 207-272-6435.
Ohio
The Ohio Department of Medicaid (ODM) announced that the enhanced COVID-19 administration reimbursement rate for pharmacies will end on Sept. 30, 2022, as the new Single Pharmacy Benefits Manager (SPBM) program takes effect.
Also in Ohio, the Board of Pharmacy issued guidance on the implementation of HB 193, which mandates electronic prescribing of Schedule II controlled substances. As the guidance notes, the law has a "safe harbor" provision which allows pharmacies to continue to fill paper prescriptions without verifying that the prescriber has an exemption. The law goes into effect on Sept. 23, 2022. Special thanks to the Ohio Council of Retail Merchants for working with NACDS and members during the legislative process to ensure that the "safe harbor" provision was included in the law.
Also in Ohio, the Board of Pharmacy posted a notice regarding license renewals for Certified Pharmacy Technicians. The renewal process opens on Aug. 1, 2022.
Finally in Ohio, the following are updates/reminders on the topic of the upcoming October implementation of the SPBM:
- To request a spreadsheet on the new dispensing fees by store location, please email medicaidspbm@medicaid.ohio.gov and include a list of your store NPI numbers.
- ODM sent a bulletin to pharmacies reminding them of important upcoming deadlines to participate in the SPBM program.
- On August 3, 2022, the Cost of Dispensing survey that will be used to set rates in both the Fee for Service and the SPBM Managed Care programs be sent out to all enrolled Medicaid pharmacies by both US Mail as well as email, if ODM has an email for the pharmacy on record. Surveys are due back on September 14, 2022. Here is a copy of the draft survey instrument.
- Myers & Stauffer will host two instructional cost of dispensing survey webinars on Aug. 11 at 3:00 PM and Aug. 16 at 8:30 AM. Information to register for the webinars will be included in the survey packet sent to pharmacies. A draft of the dispensing survey tool can be viewed here.
- For a list of specialty drugs and ingredient cost reimbursement by drug (OAAC (Ohio Average Acquisition Cost)) please visit the Myers & Stauffer Ohio Medicaid webpage.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
Oklahoma
The State Board of Pharmacy (OSBP) is requesting that pharmacies email the following information within 24 hours of pharmacy closure during normal business hours, during the time when patients would expect the pharmacy to be open.
- License number of the pharmacy
- Name of the pharmacy
- Address of the pharmacy
- Name of the Pharmacist in charge (PIC)
- Dates that the pharmacy will be closed
- Hours the pharmacy will be closed
- Detailed explanation for closing
For more information, contact NACDS’ Mary Staples at 817-442-1155.
Oregon
The Oregon State Newsletter – June 2022 has been posted to the NABP/Oregon website and includes the following information.
- No. 678 Safe Pharmacy Practice Conditions
- No. 679 Expedited Partner Therapy Updates
- No. 680 Rulemaking
- Rule Feedback
- Permanent Rules Adopted in April 2022
- Permanent Rules Adopted in June 2022
- No. 681 Compliance: Legal Advice vs Legal Information
- No. 682 Licensing: Technician Renewals Due June 30, 2022
- No. 683 REALD and Pharmacies
Also in Oregon, the Board of Pharmacy adopted the following temporary rules effective July 1, 2022, through December 27, 2022.
- OAR 855-019-0210 related to Duties of Pharmacist Receiving a Prescription
- OAR 855-139-0699 related to a Retail Drug Outlet RDSP (Remote Dispensing Site Pharmacy)
Also in Oregon, the Board of Pharmacy adopted the following permanent rules at the June 2022 Board Meeting.
- Divisions 006/041/043/045/080/139 – related to Standards Adopted by Reference & Definitions - Effective June 16, 2022
- Divisions 019/025/041 – related to Certified Oregon Pharmacy Technician/Pharmacy Technician Final Verification - Effective June 16, 2022
- Divisions 019/041/139 – related to Interpreters – Effective September 1, 2022
- Divisions 019/143 – related to Pharmacy Prescription Lockers - Effective June 16, 2022
- Division 020 – related to Pharmacist Prescriptive Authority – Tobacco Cessation & PrEP - Effective June 16, 2022
- Division 031 – related to Public Health Emergency Sunset – Effective June 16, 2022
- Division 041 – related to Telework – Effective June 16, 2022
- Divisions 041/139 – related to Permanent Pharmacy Closure Requirements – Effective June 16, 2022
- Division 080 – related to Pseudoephedrine/Ephedrine & Interns – Effective June 16, 2022
- Division 110 – related to Drug Outlet Categories – Effective June 16, 2022
- Division 139 – related to RDSP [Remote Dispensing Site Pharmacies] – Effective June 16, 2022
Finally in Oregon, effective July 1, 2022, through December 27, 2022, the Oregon Health Authority adopted a temporary rule amending OAR 410-121-0030 and 410-121-0040 in accordance with the Drug Use Review (DUR) Pharmacy & Therapeutics (P&T) Committee's recommendations made during the June 2, 2022 meeting.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
South Carolina
The South Carolina Pharmacy Association (SCPhA) is seeking a new Chief Executive Officer. The selection process will begin in July 2022 and continue until the best candidate is identified. Questions may be directed to the Selection Committee c/o Jennifer Baker, SCPhA Immediate‐Past President & Search Committee Chair at scpharmacyjlb@gmail.com
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
Texas
The Board of Pharmacy August 2nd meeting agenda includes proposed rules for final adoption on patient counseling, non-sterile compounding, and centralized prescription dispensing. If you are unable to attend the Board meeting, you can watch it on live stream.
Also in Texas, NACDS sponsored the Texas Pharmacy Association’s annual meeting keynote session with State Senator Charles Perry (R-Lubbock), the Vice-Chair of the powerful Senate Health and Human Services Committee. Last session, Sen. Perry, a vocal advocate for pharmacy benefit manager (PBM) reform, helped pass two important bills through the Senate that became law in 2021.
Also in Texas, NACDS and our in-state partner, the Texas Federation of Drug Stores, have arranged for Rep. Four Price (R) to tour a United Supermarket Pharmacy in Amarillo. (Left to Right: United pharmacist Tim Purser, pharmacy technician Danielle Coleman, pharmacist Viet Le Nguyen, NACDS’ TX lobbyist Nicole Kralj, State Rep. Four Price (R-Amarillo) and NACDS Mary Staples)
Finally in Texas, Gov. Greg Abbott (R) again extended the waiver for the requirement for pharmacists to have in-person contact for patient counseling to allow patient counseling to be performed by telephonic consultation until September 30, 2022, or until the March 13, 2020, disaster declaration is lifted or expires, whichever is earlier.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
Utah
The Board of Pharmacy posted the following:
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Washington
The Health Care Authority (HCA) revised the Apple Health (Medicaid) COVID-19 vaccine clinical policy and the Emergency COVID-19 fee schedules.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
California
On June 27, Gov. Gavin Newsom (D) signed SB (Senate Bill) 154 (Chapter 43) which includes language allocating $114.4 million to forgive the retroactive reduction of claims reimbursement for independent pharmacies in 2022-23. Another $28.4 million will be allocated in 2023-24. This was due to an error in the implementation of the actual acquisition cost reimbursement methodology for dates of service from April 1, 2017, to February 22, 2019, inclusive. On June 30, Gov. Newsom signed AB (Assembly Bill) 178 (Chapter 45) that directs the Department of Health Care Services to forego the recoupment of overpayments from independent pharmacies and defined "independent pharmacy" as a pharmacy owned by a person or entity who owns not more than 74 pharmacies in California. Also, on June 30, the Governor signed SB 184 (Chapter 47), the health trailer bill, that expands telehealth and exempts continuous glucose monitors and medication therapy management services from a 10 percent provider cut based on 2011 legislation.
Also in California, the Department of Consumer Affairs issued this waiver extension on July 11: DCA Waiver DCA-22-217 Order Waiving Restrictions on Pharmacists Independently Initiating and Furnishing Paxlovid to Individual Patients. The full waiver and a list of current waivers is available on the DCA website.
Also in California, the Board of Pharmacy recently communicated the following:
- Complaints about Pharmacy Performance Quotas
- July 18 at 9:00 a.m. – Licensing Committee Meeting Agenda and Meeting Materials
- July 18 at 1:00 p.m. – Legislation and Regulation Committee Meeting Agenda and Meeting Materials
- July 19 at 9:00 a.m. – Enforcement and Compounding Committee Meeting Agenda and Meeting Materials
- July 19 at 1:00 p.m. – Communication and Public Education Committee Meeting Agenda and Meeting Materials
Also in California, the Department of Health Care Services posted the following alerts on the Medi-Cal Rx Web Portal. Please note this week's announcement about the postponement of implementation of NCPDP (National Council for Prescription Drug Programs) reject code 80 and the reminder about the July 31 deadline for all participating Medi-Cal Rx pharmacy providers and billers to submit a Medi-Cal Rx Telecommunications Provider and Biller Application/Agreement Form to continue submitting electronic claims without interruption.
- Prescriber Advantages of Using CoverMyMeds® for Medi-Cal Rx Prior Authorization Requests (July 13)
- Update: Postponement of Implementation of NCPDP Reject Code 80 (July 12)
- Changes to Medical Supplies Reimbursement Methodology, Effective July 1, 2022 (July 8)
- Medi-Cal Rx Weekly Wrap-up for July 1-7 (July 8)
- Second Booster Dose for Targeted Populations (July 7)
- Medi-Cal Rx Training Catalog (July 5)
- Medi-Cal Rx Weekly Wrap-up for June 24-30 (July 1)
- Medi-Cal Rx Monthly Bulletin for July (July 1)
- Changes to the Contract Drugs List (CDL) (July 1)
- Changes to the Contract Drugs List (CDL) – Authorized Drug Manufacturer Labeler Codes (July 1)
- Updates to the Medi-Cal Rx Provider Manual (July 1)
- 30-Day Reminder: Electronic Claims Agreement – Submission Deadline Extended to July 31, 2022 (June 30)
- Medi-Cal Rx Office Hour – Reinstatement of Reject Codes 80 and 88 (June 29)
- Reminder: Fiscal Year Two-week Fee-for-Service Hold for Specific Provider Payments (June 29)
- Now Available: Medi-Cal Rx Telecommunications Provider and Biller Application/Agreement Form – Supplemental Form (June 27)
- Enteral Nutrition Updates Additions, Effective July 1, 2022 (June 24)
- Medi-Cal Rx Weekly Wrap-up for June 17-23 (June 24)
- Medi-Cal Rx Point-of-Sale Messaging Update (June 22)
- Appendix A: Reject Code 88 DUR: Service Codes Scenarios (June 22)
- NDPDP Reject Code 88 DUR Reference Guide (June 22)
- NCPDP Reject Code 80 Reference Guide (June 22)
- 30-Day Countdown – Reinstatement of Reject Codes 80 and 88 (June 22)
- Medi-Cal Rx Weekly Wrap-up for June 10-16 (June 17)
Finally in California, the Department of Health Care Services posted the "August 2022 Medi-Cal Provider Training Webinars".
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Delaware
Both Houses of the legislature passed SB 399 that authorizes a pharmacist to order, test, screen, and treat certain health conditions pursuant to a statewide written protocol for CLIA waived tests approved by the Division of Public Health. This legislation is pending Governor Carney’s (D) signature.
For more information, please contact NACDS’ Mike Sargent at 207-272-6435.
Florida
Governor Ron DeSantis (R) issued an Executive Order to address the cost of prescription drugs in the state. The order directs all executive agencies to include provisions in all future contracts and solicitations with PBMs (Pharmacy Benefits Managers) (Pharmacy Benefit Manager), services that include the following:
- Prohibit spread pricing for all PBMs
- Prohibit reimbursement claw backs for all PBMs
- Directs agencies to include reporting requirements and data transparency, including a review of all rebates, payments, and relationships between pharmacies, insurers, and manufacturers
- Directs all impacted agencies to amend all contracts with these same provisions.
Also in Florida, the Agency for Health Care Administration (Agency) has been implementing Referring, Ordering, Prescribing, and Attending (ROPA) requirements as directed by the 21st Century Cures Act (Cures Act) and by the Centers for Medicare and Medicaid Services (CMS). Previous provider alerts on National Provider Identifier (NPI) requirements for ROPA providers can be found on the Agency's website in the Provider Message Archive. Providers must be enrolled with Florida Medicaid in accordance with Title 42, Code of Federal Regulations, Section 455.410(b).
In accordance with CMS requirements, all Fee-For-Service claims submitted October 1, 2022, or after from a non-exempt provider type that do not have a ROPA provider listed on the claim will be denied. The exempted provider types that will not require a ROPA on the claim are listed below, all other provider type claims must have a ROPA provider identified by NPI on the claim for reimbursement by Florida Medicaid.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
Iowa
The Iowa Medicaid Enterprise (IME) released the final July 2022 Cost of Dispensing (COD) Report with the following results:
- The report reflects the mean cost of dispensing, weighted by Medicaid volume, was $10.97 per prescription for all pharmacies, including specialty pharmacies.
- For non-specialty pharmacies only, the mean cost of dispensing, weighted by Medicaid volume, was $10.18 per prescription.
IME stated the current dispensing fee of $10.38 will remain in place until additional state funding is appropriated by the Legislature next session to increase the dispensing fee to $10.97. A state plan amendment (SPA) would also be required, if funding is approved, and the increase would be prospective following CMS approval of the SPA.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Massachusetts
The Massachusetts House of Representatives passed HB 4930 "Relative to Expanding Access to Reproductive Rights" by a vote of 136 – 17. This bill will now be considered by the State Senate. This legislation provides legal protections for Massachusetts health care providers, including pharmacists, from prosecution by out-of-state jurisdictions for legally protected health care and reproductive health care services and products provided in Massachusetts to out-of-state residents. This language is designed to protect these providers from criminal prosecution and associated civil lawsuits from states that prohibit access to legal health care and reproductive health services and products.
Also in Massachusetts, the Commonwealth's Senate today unanimously passed SB 2955 which will allow pharmacists to prescribe, dispense and administer HIV prevention drugs. This bill now goes to the House for their consideration.
Finally in Massachusetts, the Board of Pharmacy has announced that additional guidance will be provided now that the FDA (Food and Drug Administration) (Food and Drug Administration) has updated the emergency use authorization (EUA) for Paxlovid™ to permit prescribing by pharmacists, subject to the terms of that EUA. Any prescribing must comply with the Emergency Use Authorization (EUA) and DPH's prescribing guidance.
For more information, please contact NACDS’ Mike Sargent at 207-272-6435.
Mississippi
The Mississippi Division of Medicaid (DOM), on July 1, 2022, will reestablish payment methods for the ingredient costs of prescription drugs that existed prior to the July 1, 2021 rate freeze. This change will remove the freeze for dates of service on or after July 1, 2022. DOM has been in frequent communication with the Centers for Medicare and Medicaid Services (CMS) regarding State Plan Amendment 21-0018, which was submitted last year to freeze reimbursement for outpatient drugs in compliance with Senate Bill 2799 as passed during the 2021 Legislative Session. While CMS has not yet taken official action, DOM anticipates CMS will disapprove SPA 21-0018. Once this disapproval is received from CMS, DOM will reprocess fee-for-service claims for prescription drugs with dates of service between July 1, 2021, and June 30, 2022.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
Nebraska
The Department of Health and Human Services (DHHS) announced the new fee schedule for injectables effective July 1, 2022.
Also in Nebraska, the DHHS issued a notice of public hearing on August 8 for proposed changes to Title 471, Chapter 7 of the Nebraska Administrative Code (NAC) – Durable Medical Equipment, Prosthetics, Orthotics, and Medical Supplies (DMEPOS).
Also in Nebraska, the DHHS posted the July 12 DUR (Drug Utilization Review) Board Meeting Agenda and the May 10 Draft Minutes.
Also in Nebraska, the DHHS published Provider Bulletin 22-12: Changes to Nebraska Medicaid Preferred Drug List (PDL) effective July 22.
Finally in Nebraska, the DHHS posted the following:
- Medicaid's next COVID update call will be held on Wednesday, August 3 at noon (Central). Call details will be added at this website one week before the call.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
New Hampshire
Governor Sununu (R) signed NH SB 229 into law, expanding the authority of qualified pharmacy technicians to immunize. A pharmacist, pharmacy intern, [or] licensed advanced pharmacy technician, or certified pharmacy technician, under the supervision of an on-site immunizing pharmacist may administer influenza and a COVID-19 vaccine, if available, to the public. A pharmacist, pharmacy intern, or licensed advanced pharmacy technician, under the supervision of an on-site pharmacist may administer Hemophilus influenza, hepatitis A, hepatitis B, hepatitis A and B, human papillomavirus, meningococcal, pneumococcal, tetanus, and diphtheria, varicella, zoster, MMR (measles, mumps, and rubella), and Tdap (tetanus, diphtheria, and pertussis) vaccines, which have been approved by the Food and Drug Administration, to individuals 18 years of age or older as ordered by an immunizing pharmacist. This law goes into effect 90 days after July 27.
Also in New Hampshire, Governor Sununu (R) vetoed NH HB (House Bill) 1022 which would have permitted Ivermectin to be dispensed via standing order.
For more information, please contact NACDS’ Mike Sargent at 207-272-6435.
North Carolina
Governor Roy Cooper (D) has signed the 2022/2023 budget. Of importance to NACDS (National Association of Chain Drug Stores) members, language was added to extend from June 30, 2023, to June 30, 2026, pharmacy reimbursement being tied to the fee-for-service rate of NADAC (National Average Drug Acquisition Cost) plus a $10.24 dispensing fee. Language was also added to extend the State Health Director's authority to issue statewide standing orders for COVID tests and vaccines until December 31, 2023 and maintains all the current statewide standing orders currently in place until rescinded by the State Health Director. This will ensure Pharmacies will continue to get reimbursed for the administration of the COVID vaccination and tests by North Carolina Medicaid. Finally, a provision was added to reauthorize the dispensing of biosimilars and the requirement for pharmacists to input patient information into a system that can be accessed by prescribers for biosimilar interchangeable. This can be achieved by processing the prescription through a PBM (Pharmacy Benefit Manager) or an electronic health record.
Also in North Carolina, the Department of Health and Human Services is establishing Community Access Points in all 100 counties where North Carolinians can find free and easy at-home tests, to meet people where they are, with the tools they need to protect themselves from COVID-19.
Community organizations interested in becoming a Community Access Point can register online. Information on where to find at-home tests is available at: covid19.ncdhhs.gov/PickUpTests. Information on how and where to find all testing locations in North Carolina is available at: covid19.ncdhhs.gov/FindTests.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
Ohio
On July 19 at 11am ET, the Department of Medicaid (ODM) will hold an online seminar with Myers & Stauffer to discuss the upcoming mandatory Pharmacy Cost of Dispensing Survey. NACDS emailed the information to join the online seminar to members on our Ohio list. However, if you need the call-in information, please contact Jill McCormack.
Also in Ohio, Myers & Stauffer has published the Specialty Drug list to be implemented in October concurrent with the new Single PBM program.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
Oregon
The Board of Pharmacy posted a public notice and agenda for the Safe Pharmacy Practice Conditions Workgroup meeting scheduled for July 18.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Pennsylvania
Gov. Wolf (D) has signed HB 2679 as Act 80 of 2022. The law, which was effective upon signing, allows pharmacists and pharmacy interns to administer COVID and flu vaccines to children down to the age of 5. The bill also makes a few COVID pharmacy waivers permanent related to pharmacist supervision of other vaccinators.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
Tennessee
Tennessee Pharmacy Association is looking for Champion Advocates to host legislators in their pharmacy or hospital, including members of Congress during the August recess. Please contact Anthony@TNPharm.org to express your interest.
Also in Tennessee, please see the updates to the PDL, Clinical Criteria, and Interim Criteria for July 2022. These changes went into effect on July 1st.
Finally in Tennessee, the Tennessee Department of Health (TDH) is hosting an Alzheimer's Disease and Related Dementias Healthcare Provider Conference on Friday, July 22, 2022, and will offer FREE Continuing Medical Education (CME) credits for participating providers (offered through TMA). Online sessions will be available one week after the conference concludes for providers that cannot attend the live event. Questions and to register – Visit their website
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
California
This week, the State Health and Human Services Agency Secretary and the Director of the State Department of Public Health along with the State Public Health Officer issued a joint statement supporting the recommendation by the Western States Scientific Safety Review Workgroup, the U.S. Centers for Disease Control (CDC), the American Academy of Pediatrics and the Federal Food and Drug Administration (FDA) to grant emergency use authorization (EUA) of the Pfizer-BioNTech and Moderna COVID-19 vaccines for children as young as 6 months of age.
Also in California, the Board of Pharmacy sent a notice about reissued pharmacy law waivers in response to Gov. Gavin Newsom's (D) declaration of emergency and the nation declaration of emergency.
- Staffing Ratio of Pharmacists to Intern Pharmacists and General Supervision and Interprofessional Supervision – Immunizations – BPC section 4114 – The amended expiration date is December 31, 2022, or until 30 days after the emergency declaration is lifted, whichever is sooner.
- Mass Vaccination Sites – The amended expiration date is December 31, 2022, or until 30 days following the declared disaster, whichever is sooner.
- Prescriber Dispensing of COVID-19 Antiviral Medication to an Emergency Room Patient (including BPC sections 4068(a)(1), 4068(a)(5), 4068(a)(6), 4076.5, and 4427.2(a)) – The amended expiration date is 30 days following the end of the declared disaster.
These waivers and all Pharmacy Law waivers are posted under COVID-19 Updates and Resources on the Board's website.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Florida
Florida Governor Ron DeSantis (R) signed into law on June 20, 2022, House Bill 357 which requires a health insurer or health maintenance organization providing pharmacy benefits through a group health insurance policy, including a pharmacy benefit manager, must comply with audit requirements. In addition, the legislation provides a penalty for failure to register as a pharmacy benefit manager. The law takes effect July 1, 2022.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
Illinois
The HFS (Healthcare and Family Services) Illinois Drugs and Therapeutics Advisory Board’s quarterly meeting will be held on Thursday, July 14, 2022. Call in information can be found here. Pre-registration is required.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.